Actinium Pharmaceuticals, Inc. (ATNM) Return On Equity % 2020 - 2023

Historical data

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Actinium Pharmaceuticals, Inc. quarterly Return On Equity history and growth rate from 2020 to 2023.
  • Actinium Pharmaceuticals, Inc. Return On Equity for the quarter ending March 31, 2023 was -57 %, a 75.8% decline year-over-year.
Return On Equity, Quarterly Data (%)
Period Value YoY Chg Change % Start Date End Date
Q1 2023 -57 -24.6 -75.8% Jan 1, 2023 Mar 31, 2023
Q4 2022 -46.4 -13.9 -42.8% Oct 1, 2022 Dec 31, 2022
Q4 2022 -46.4 -13.9 -42.8% Jan 1, 2022 Dec 31, 2022
Q3 2022 -41.6 -10 -31.7% Jul 1, 2022 Sep 30, 2022
Q2 2022 -36.3 -1.82 -5.27% Apr 1, 2022 Jun 30, 2022
Q1 2022 -32.4 +5.88 +15.3% Jan 1, 2022 Mar 31, 2022
Q4 2021 -32.5 +22.9 +41.3% Oct 1, 2021 Dec 31, 2021
Q4 2021 -32.5 +22.9 +41.3% Jan 1, 2021 Dec 31, 2021
Q3 2021 -31.6 +46.4 +59.5% Jul 1, 2021 Sep 30, 2021
Q2 2021 -34.5 Apr 1, 2021 Jun 30, 2021
Q1 2021 -38.3 Jan 1, 2021 Mar 31, 2021
Q4 2020 -55.4 Oct 1, 2020 Dec 31, 2020
Q4 2020 -55.4 Jan 1, 2020 Dec 31, 2020
Q3 2020 -78 Jul 1, 2020 Sep 30, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.